Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
prednisolonacetat 5 mg + natriumsulfacetamid 100 mg, suspension | Is a | Product containing prednisolone (medicinal product) | false | Inferred relationship | Some | ||
prednisolonacetat 5 mg + natriumsulfacetamid 100 mg, suspension | Is a | Product containing sulfacetamide (medicinal product) | false | Inferred relationship | Some | ||
prednisolonacetat 5 mg + natriumsulfacetamid 100 mg, suspension | Is a | Product containing prednisolone in ocular dose form (medicinal product form) | false | Inferred relationship | Some | ||
prednisolonacetat 5 mg + natriumsulfacetamid 100 mg, suspension | Is a | sulfonamidpreparat för oftalmiskt bruk | false | Inferred relationship | Some | ||
prednisolonacetat 5 mg + natriumsulfacetamid 100 mg, suspension | Has active ingredient | Sulfacetamide (substance) | false | Inferred relationship | Some | ||
prednisolonacetat 5 mg + natriumsulfacetamid 100 mg, suspension | Has active ingredient | Prednisolone ophthalmic preparation | false | Inferred relationship | Some | ||
prednisolonacetat 5 mg + natriumsulfacetamid 100 mg, suspension | Has active ingredient | Sulfonamide (substance) | false | Inferred relationship | Some | ||
prednisolonacetat 5 mg + natriumsulfacetamid 100 mg, suspension | Has active ingredient | Sulfacetamide sodium | false | Inferred relationship | Some | ||
prednisolonacetat 5 mg + natriumsulfacetamid 100 mg, suspension | Has active ingredient | Corticosterone | false | Inferred relationship | Some | ||
prednisolonacetat 5 mg + natriumsulfacetamid 100 mg, suspension | Has active ingredient | Prednisolone acetate | false | Inferred relationship | Some | ||
prednisolonacetat 5 mg + natriumsulfacetamid 100 mg, suspension | Is a | prednisolonacetat + natriumsulfacetamid | false | Inferred relationship | Some | ||
prednisolonacetat 5 mg + natriumsulfacetamid 100 mg, suspension | Has active ingredient | binjurehormonmedel | false | Inferred relationship | Some | ||
prednisolonacetat 5 mg + natriumsulfacetamid 100 mg, suspension | Has active ingredient | Bactericide | false | Inferred relationship | Some | ||
prednisolonacetat 5 mg + natriumsulfacetamid 100 mg, suspension | Has active ingredient | Glucocorticoid hormone | false | Inferred relationship | Some | ||
prednisolonacetat 5 mg + natriumsulfacetamid 100 mg, suspension | Has manufactured dose form | Ocular dose form (dose form) | false | Inferred relationship | Some | ||
prednisolonacetat 5 mg + natriumsulfacetamid 100 mg, suspension | Has manufactured dose form | läkemedelssuspension | false | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set